Alvotech

NASDAQ:ALVO   4:00:00 PM EDT
7.93
-0.03 (-0.38%)
7:15:20 PM EDT: $7.93 0.00 (0.01%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.39B
Current PE37.77
Forward PE 26.43
2yr Forward PE 10.43
See more stats
Estimates Current Quarter
Revenue$117.2 Million
Adjusted EPS-$0.02
See more estimates
10-Day MA$8.05
50-Day MA$8.53
200-Day MA$10.29
See more pivots

Alvotech Stock, NASDAQ:ALVO

9, rue de Bitbourg, 28th floor, Luxembourg, Luxembourg 1273
Luxembourg
Phone: +352.422.4500
Number of Employees: 1026

Description

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by R�³bert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.